Health & Biotech
ASX Health Stocks: MVP flies high after disclosing US ‘green whistle’ strategy, Imricor signs with prestigious Swiss hospital
Q+A: Proteomics MD Richard Lipscombe on its potential US breakthrough with Sonic Healthcare
Weed Week: Most Aussies still use illicit cannabis, but more are now turning to prescriptions
Stock Insiders: Argenica progresses to Phase 2 clinical trial in stroke patients with ARG-007
ASX Health Stocks: Noxopharm plunges 45pc after discontinuing Veyonda clinical trials
ASX Health Stocks: Atomo and Volpara strike $1m+ contracts; Estia tells Bain to improve $3 offer
EZZ Life Science brand EAORON launches SIX new products with Chemist Warehouse
ASX Health Stocks: Paradigm shows good Phase 2 results, Race Oncology jumps 8pc after third party report on Zantrene
Health Kick Podcast: Prescient Therapeutics’ PTX-100 continues to show encouraging results following FDA Orphan Drug Designation
ASX Health Stocks: PYC to take second asset to clinical trial; FDA sees no issues in Botanix submission
MGC Pharma granted approval in Slovenia to manufacture and conduct research into the burgeoning space of psychedelics
Dr Boreham’s Crucible: Every sperm is sacred – and profitable
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update
ASX Health Stocks: Patrys crashes after Phase 1 delayed till 2024, Nova Eye surges 20pc on FDA OK
Nova Eye Medical secures FDA clearance for iTrack Advance to treat glaucoma
Argenica secures significant non-dilutive funding for preclinical studies into newborn brain injury
ASX Health Stocks: Cyclopharm sends reply to FDA, the final step before potential approval
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
